BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/3/2026 6:28:05 AM | Browse: 1 | Download: 1
 |
Received |
|
2025-10-24 12:29 |
|
Peer-Review Started |
|
2025-10-24 12:29 |
|
First Decision by Editorial Office Director |
|
2025-11-05 07:45 |
|
Return for Revision |
|
2025-11-05 07:45 |
|
Revised |
|
2025-11-13 08:29 |
|
Publication Fee Transferred |
|
2025-11-18 09:08 |
|
Second Decision by Editor |
|
2025-12-11 02:46 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-12-11 08:13 |
|
Articles in Press |
|
2025-12-11 08:13 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-01-26 08:26 |
|
Publish the Manuscript Online |
|
2026-02-03 06:28 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Clinical characteristics of programmed death-1 inhibitors for older patients with advanced pancreatic cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Yun-Yun Lu, Pan Chen and Yi Lu |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yun-Yun Lu, Department of Radiation Oncology, Ningbo Medical Center Lihuili Hospital, No. 1111 Jiangnan Road, Ningbo 315048, Zhejiang Province, China. lhlluyunyun@nbu.edu.cn |
| Key Words |
Advanced pancreatic cancer; Older adults; Programmed death-1 inhibitors; Eastern Cooperative Oncology Group performance status; Prognostic nutritional index; Triglyceride |
| Core Tip |
This study identified prognostic factors for older patients with advanced pancreatic cancer treated with programmed death-1 (PD-1) inhibitors. The findings indicated that PD-1 inhibitor therapy was safe in this older population. Key predictors of treatment prognosis included the Eastern Cooperative Oncology Group performance status, prognostic nutritional index, and triglyceride levels. |
| Publish Date |
2026-02-03 06:28 |
| Citation |
Lu YY, Chen P, Lu Y. Clinical characteristics of programmed death-1 inhibitors for older patients with advanced pancreatic cancer. World J Gastrointest Oncol 2026; 18(2): 115562 |
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i2/115562.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v18.i2.115562 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
